Simply put: COVID-19 vaccine exploration

Simply put: Let’s plant a COVID-19 vaccine

Simply Put: The vaccine

येल यूनिवर्सिटी ने फाइब्रोसिस की खोजी नयी दवा, कोविड-19 के इलाज में हो सकती है सहायक

येल यूनिवर्सिटी के शोधकर्ताओं द्वारा खोजी गयी 'सोबेट्रियम' नामक यह दवा कोविड-19 के मरीजों में होने वाले एक्यूट रेस्पिरेटरी डिस्ट्रेस सिंड्रोम की रोकथाम और उपचार में कारगर ...

Simply Put: Russian COVID-19 vaccine

COVID-19: Do antibodies hold the key

Watch what new research in Israel, the Netherlands have come up with 

A promise of equitable access to all

WHO, pharma giants and governments have come together to provide access to all on COVID-19 therapies. But will WIPO allow this to happen?

Simply Put: COVID-19 and Sri Ram’s arrow

COVID-19: Trials for cure at a glance

Scientists across the globe are working to develop vaccines for the novel coronavirus disease while exploring whether existing drugs can be …

No COVID-19 vaccine before 2021, Centre puts out then deletes

Sentence in question inadvertently included: PIB official; Things are contextual, says author of original article 

COVID-19: Phase 3 of vaccine developed by Chinese researchers underway, says Lancet

The Ad5-vectored COVID-19 vaccine tested on people above 55 years of age, is considered a step up from another vaccine being developed by the UK

COVID-19: What will be a fair policy to distribute vaccine

No country is safe if only its own citizens are inoculated; the question of equitable distribution of a vaccine is as much a global concern as it …

COVID-19: Extensive research underway; how much will it help?

As many as 42 vaccines were in preclinical stage and two vaccines in Phase I clinical trials as of March 20, according to WHO  

COVID-19: Can antigen test be a game-changer?

Unlike commonly available COVID-19 tests that use polymerase chain reaction, antigen diagnostics work by quickly detecting fragments of virus in …

Coronavirus update: US FDA cautions consumers against toxin in hand sanitisers

India registers highest single-day spike of 66,999 cases August 13; 942 deaths added in 24 hours 

Phase 1 human trials of Oxford University encouraging: Lancet

The sample size will have to be expanded across demography to check safety and efficacy  

Travel post COVID-19: Providing thrust to digital booking

Why e-ticketing introduced in post-globalisation era will be boon in post-COVID-19 one 

Did Dharavi model work? Is it herd immunity or plain luck?

As cases mounted and the toll rose, the bylanes of Dharavi kept waiting for the system to kick in; for many, the wait never ended

COVID-19 vaccine development: It’s a relay race

The reason trials are taking shorter time is because developers are taking more risks

Smoke and mirrors on COVID-19 drugs?

In a brutal fight to corner the successful outcome of research, governments are openly using money power to grab the first rights to promising …

Simply Put: Hand washing and COVID-19

Simply Put: COVID-19 and students

How ‘good’ does a COVID-19 vaccine need to be? A new study has answers

A vaccine with an efficacy as low as 60% could still stop the pandemic. However, most, if not all of the population, would have to be vaccinated

Fast COVID-19 vaccine timelines are unrealistic, put integrity of scientists at risk

No vaccine against a coronavirus has successfully navigated the rigours of clinical testing, despite having up to 17 years to do so

Coronavirus update: India tally crosses 2 lakh

Number of active cases crossed 1 lakh mark